Description

Trifas 20 (Torasemide) Solution for Injections 20 mg/4 ml. Vials №5

Ingredients:

• Each vial contains 20 mg of Torasemide in a 4 ml solution for injections.

Dosage:

• The usual adult dose is 10-20 mg once daily, administered by injection.

Indications:

• Trifas 20 is indicated for the treatment of edema associated with congestive heart failure, renal disease, or hepatic disease.

Contraindications:

• Do not use Trifas 20 if you are allergic to Torasemide or if you have anuria.

Directions:

• Administer Trifas 20 by slow intravenous injection. Dosage may vary based on individual patient response.

Scientific Evidence:

Studies have shown that Torasemide, the active ingredient in Trifas 20, is effective in reducing edema and improving symptoms in patients with heart failure. Torasemide has been found to have a longer duration of action compared to other loop diuretics, making it a preferred choice in the management of fluid retention.

Additional Information:

• It is important to monitor electrolyte levels and renal function regularly while using Trifas 20 to prevent any complications.
• This medication may cause dizziness or dehydration, so caution is advised when driving or operating machinery.
• Trifas 20 has been well-tolerated in clinical trials, with common side effects including hypokalemia and hypotension.
• Patients should be educated on the signs of electrolyte imbalances and instructed to seek medical help if they experience any concerning symptoms.